We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$13B
AUM Growth
-$11.4M
Cap. Flow
-$113M
Cap. Flow %
-0.87%
Top 10 Hldgs %
14.49%
Holding
2,617
New
35
Increased
809
Reduced
690
Closed
108

Sector Composition

Rank Sector Weight
1 Technology 13.12%
2 Financials 12.56%
3 Healthcare 12.08%
4 Industrials 10.3%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
2526
Tvardi Therapeutics
TVRD
$22.1M
-371
Closed -$225K
CDMO
2527
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-21,562
Closed -$177K
NSTG
2528
DELISTED
NanoString Technologies, Inc.
NSTG
-10,449
Closed -$154K
ARAV
2529
DELISTED
Aravive, Inc. Common Stock
ARAV
-2,814
Closed -$209K
CORR
2530
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
-1
Closed
NEWR
2531
DELISTED
New Relic, Inc.
NEWR
-4,418
Closed -$161K
ACGN
2532
DELISTED
Aceragen Inc
ACGN
-470
Closed -$197K
KDNY
2533
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-1,325
Closed -$186K
MGI
2534
DELISTED
MoneyGram International, Inc. New
MGI
-17,544
Closed -$110K
CFMS
2535
DELISTED
Conformis, Inc. Common Stock
CFMS
-481
Closed -$208K
CCXI
2536
DELISTED
ChemoCentryx, Inc.
CCXI
-22,688
Closed -$184K
GBT
2537
DELISTED
Global Blood Therapeutics, Inc.
GBT
-7,158
Closed -$231K
HNGR
2538
DELISTED
Hanger Inc.
HNGR
-26,034
Closed -$428K
ATRS
2539
DELISTED
Antares Pharma, Inc.
ATRS
-116,522
Closed -$141K
DRNA
2540
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-11,866
Closed -$141K
FLXN
2541
DELISTED
Flexion Therapeutics, Inc.
FLXN
-10,534
Closed -$203K
RNET
2542
DELISTED
RigNet, Inc.
RNET
-11,427
Closed -$236K
VSLR
2543
DELISTED
VIVINT SOLAR, INC.
VSLR
-16,921
Closed -$162K
PFNX
2544
DELISTED
Pfenex Inc.
PFNX
-12,344
Closed -$153K
TTPH
2545
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-1,265
Closed -$254K
UPL
2546
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
-150,082
Closed -$375K
NAVB
2547
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-5,703
Closed -$152K
ARRS
2548
DELISTED
ARRIS International plc Ordinary Shares
ARRS
-123,357
Closed -$3.77M
SPA
2549
DELISTED
Sparton
SPA
-8,302
Closed -$166K
EQGP
2550
DELISTED
EQGP Holdings, LP
EQGP
-20,579
Closed -$427K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q1 2016 Portfolio in Review

As of Q1 2016, Metropolitan Life Insurance Company (MetLife) held 2,617 positions worth $13B, down 0.09% from $13B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q1 2016 filing shows 35 new, 809 increased, 690 reduced and 108 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,319,606 shares worth $157M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $27.8M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q1 2016 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,319,606 shares worth $157M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Value ETF in Q1 2016, an estimated $6.72M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $27.8M.
  • Metropolitan Life Insurance Company (MetLife) fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $17.3M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13B portfolio in Q1 2016.
  • Metropolitan Life Insurance Company (MetLife) opened 35 new positions and closed 108 in Q1 2016.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 0.09% quarter-over-quarter to $13B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2016, filed 16 May 2016.